Indo Us Bio-Tech Stock

Indo Us Bio-Tech P/FCF

The P/FCF (Price-to-Free-Cash-Flow Ratio) of Indo Us Bio-Tech (INDOUS.NS) as of Aug 15, 2026 is 479.14. In the previous year, P/FCF (Price-to-Free-Cash-Flow Ratio) was -37.12 — a change of -1,390.68% (higher).

P/FCF

479.14

YoY

-1,390.68%

Last updated:

P/FCF (Price-to-Free-Cash-Flow Ratio) of Indo Us Bio-Tech is 2026 479.14 . P/FCF (Price-to-Free-Cash-Flow Ratio) of Indo Us Bio-Tech was 2025 -37.12 . It decreases by -1,390.68% higher compared to the previous year.
Access this data via the Eulerpool API

Indo Us Bio-Tech Stock analysis

What does Indo Us Bio-Tech do? Indo Us Bio-Tech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Indo Us Bio-Tech stock

P/FCF (Price-to-Free-Cash-Flow Ratio) of Indo Us Bio-Tech is 479.14 in 2026.

P/FCF (Price-to-Free-Cash-Flow Ratio) of Indo Us Bio-Tech changed from -37.12 to 479.14, representing a -1,390.68% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of P/FCF (Price-to-Free-Cash-Flow Ratio) Indo Us Bio-Tech since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Free-Cash-Flow ratio measures how much investors pay for each unit of free cash flow. A lower ratio may indicate better value.

P/FCF = Market Capitalization / Free Cash Flow

To evaluate P/FCF (Price-to-Free-Cash-Flow Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/FCF (Price-to-Free-Cash-Flow Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/FCF (Price-to-Free-Cash-Flow Ratio)'s Indo Us Bio-Tech with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Indo Us Bio-Tech

All Key Metrics — Indo Us Bio-Tech